ValiRx (VAL) Competitors GBX 0.56 +0.01 (+1.82%) As of 07/11/2025 12:01 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock VAL vs. NOG, HNR, SUN, EOG, WRES, EQT, CRC, WEB, NBL, and FTOShould you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include Nostrum Oil & Gas (NOG), Highlands Natural Resources (HNR), Surgical Innovations Group (SUN), Europa Oil & Gas (EOG), W Resources (WRES), EQTEC (EQT), Circle Property (CRC), Webis (WEB), 18564 (NBL.L) (NBL), and 2059984 (FTO.L) (FTO). These companies are all part of the "petroleum and natural gas" industry. ValiRx vs. Its Competitors Nostrum Oil & Gas Highlands Natural Resources Surgical Innovations Group Europa Oil & Gas W Resources EQTEC Circle Property Webis 18564 (NBL.L) 2059984 (FTO.L) ValiRx (LON:VAL) and Nostrum Oil & Gas (LON:NOG) are both small-cap petroleum and natural gas companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk. Is VAL or NOG more profitable? Nostrum Oil & Gas has a net margin of -59.05% compared to ValiRx's net margin of -20,554.01%. Nostrum Oil & Gas' return on equity of 74.84% beat ValiRx's return on equity.Company Net Margins Return on Equity Return on Assets ValiRx-20,554.01% -55.84% -35.98% Nostrum Oil & Gas -59.05%74.84%1.53% Do analysts prefer VAL or NOG? Nostrum Oil & Gas has a consensus target price of GBX 6, indicating a potential upside of 98.68%. Given Nostrum Oil & Gas' stronger consensus rating and higher probable upside, analysts plainly believe Nostrum Oil & Gas is more favorable than ValiRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ValiRx 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nostrum Oil & Gas 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer VAL or NOG? In the previous week, ValiRx's average media sentiment score of 0.00 equaled Nostrum Oil & Gas'average media sentiment score. Company Overall Sentiment ValiRx Neutral Nostrum Oil & Gas Neutral Which has more volatility and risk, VAL or NOG? ValiRx has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Comparatively, Nostrum Oil & Gas has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Do institutionals & insiders have more ownership in VAL or NOG? 22.3% of Nostrum Oil & Gas shares are held by institutional investors. 18.3% of ValiRx shares are held by company insiders. Comparatively, 44.3% of Nostrum Oil & Gas shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has preferable valuation & earnings, VAL or NOG? ValiRx has higher earnings, but lower revenue than Nostrum Oil & Gas. ValiRx is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioValiRx£27.78K76.53-£5.71M-£1.48-0.38Nostrum Oil & Gas£206.12M0.04-£121.71M-£29.66-0.10 SummaryNostrum Oil & Gas beats ValiRx on 10 of the 13 factors compared between the two stocks. Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VAL vs. The Competition Export to ExcelMetricValiRxBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£2.13M£129.37M£5.60B£3.00BDividend Yield0.63%3.74%5.24%5.02%P/E Ratio-0.383.4727.96150.83Price / Sales76.534,141.03430.89314,599.98Price / Cash62.5013.1937.4627.97Price / Book0.2142.088.044.59Net Income-£5.71M-£92.15M£3.18B£5.90B7 Day Performance-6.67%1.25%3.63%11.51%1 Month Performance12.00%4.29%4.04%7.92%1 Year Performance-79.43%174.68%29.55%32.06% ValiRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VALValiRxN/AGBX 0.56+1.8%N/A-79.8%£2.13M£27.78K-0.385,450Gap UpNOGNostrum Oil & Gas1.3015 of 5 starsGBX 3.11-10.0%GBX 6+93.2%-40.3%£8.18M£206.12M-0.1030Gap DownHNRHighlands Natural ResourcesN/AN/AN/AN/A£6.95M£1.02M-0.9616Gap DownHigh Trading VolumeSUNSurgical Innovations GroupN/AGBX 0.71+1.4%N/A-1.3%£6.62M£12.54M-21.1180News CoverageGap DownEOGEuropa Oil & GasN/AGBX 0.51+2.2%N/A-50.3%£4.90M£3.57M-0.722,850WRESW ResourcesN/AN/AN/AN/A£3.89M£3.47M-0.4366Gap DownEQTEQTECN/AGBX 0.43-4.4%N/A-60.7%£1.11M£3.85M-2.53740Gap UpHigh Trading VolumeCRCCircle PropertyN/AN/AN/AN/A£1.02M£7.57M50.001,060Gap DownHigh Trading VolumeWEBWebisN/AN/AN/AN/A£157K£49.70M14.1350Gap DownNBL18564 (NBL.L)N/AN/AN/AN/A£0.00N/A0.002,330FTO2059984 (FTO.L)N/AN/AN/AN/A£0.00N/A0.00147,000 Related Companies and Tools Related Companies Nostrum Oil & Gas Alternatives Highlands Natural Resources Alternatives Surgical Innovations Group Alternatives Europa Oil & Gas Alternatives W Resources Alternatives EQTEC Alternatives Circle Property Alternatives Webis Alternatives 18564 (NBL.L) Alternatives 2059984 (FTO.L) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VAL) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
